Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesEvaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder
Current Medical Research and Opinion, 09/30/09
Montoya A et al. – A continued improvement of symptoms is expectable until 12 weeks in treatment–naïve ADHD patients treated with atomoxetine as first–line medication. Chief limitations are the small, national sample size and the absence of data beyond the 12–week time–point.
Related Articles
Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder
Current Medical Research and Opinion, 10/02/09
Relevance Score: 96%
Electrocardiographic Screening in Children With Attention-Deficit Hyperactivity Disorder
The American Journal of Cardiology, 10/22/09
Relevance Score: 94%
Comorbidity in Adults With Attention-Deficit Hyperactivity Disorder
Canadian Journal of Psychiatry, 10/20/09
Relevance Score: 94%
Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder
Yonsei Medical Journal, 10/29/09
Relevance Score: 93%
Dopaminergic Haplotype as a Predictor of Spatial Inattention in Children With Attention-Deficit/Hyperactivity Disorder
Archives of General Psychiatry, 10/09/09
Relevance Score: 93%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/03/09
Health related quality of life in early Parkinsons disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort
Parkinsonism & Related Disorders, 12/03/09
Safety and Tolerability of Donepezil in Mild Cognitive Impairment: Open-Label Extension Study
American Journal of Alzheimer's Disease and Other Dementias, 12/03/09
Sponsor
Article Search
Sponsor